Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging

Skeletal Radiology

Volumn 40, Issue 3, 2011, Pages 295-302

  Su, Ming Gang ^a   Tian, Rong ^a   Fan, Qiu Ping ^a   Tian, Ye ^a   Li, Fang Lan ^a   Li, Lin ^a   Kuang, An Ren ^a   Miller, John Howard ^b  

^a SICHUAN UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

18F FDG; Children and adults; Fibrous dysplasia; PET CT; Skeletal dysplasia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE BIOPSY; BONE METASTASIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROUS DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROUS DYSPLASIA OF BONE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79953812592     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-010-0999-9     Document Type: Article

References (22)

1. Campanacci M. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. 2nd ed. New York: Springer; 1999.
2. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the Mc-Cune-Albright Syndrome. N EngI J Med. 1991;325:1688-95.
3. DiCaprio MR, Enneking WF. Fibrous dysplasia. pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87:1848-64. (Pubitemid 41061209)
4. Parekh SG, Donthineni-Rao R, Ricchetti E, Lackman RD. Fibrous dysplasia. J Am Acad Orthop Surg. 2004;12:305-13.
5. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol. 2004;182:1389-98. (Pubitemid 38668837)
6. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-7.
7. Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540-8. (Pubitemid 39663420)
8. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774-7. (Pubitemid 32476270)
9. Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med. 2000;41:1695-701.
10. 18F]-FDG in fibrous dysplasia can mimic skeletal involvement in Hodgkin's disease. Eur J Nucl Med Mol Imaging. 2008;35:223.
11. Stegger L, Juergens KU, Kliesch S, Wormanns D, Weckesser M. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol. 2007;17:1784-6. (Pubitemid 46909666)
12. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology. 2003;227:617-28.
13. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med. 2007;48:1761-6.
14. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871-5.
15. Hart ES, Kelly MH, Brillante B, Chen CC, Ziran N, Lee JS, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res. 2007;22:1468-74. (Pubitemid 351339693)
16. Terpstra L, Rauch F, Plotkin H, Travers R, Glorieux FH. Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis. J Bone Miner Res. 2002;17:1949-53. (Pubitemid 35239195)
17. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-80.
18. 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol. 2006;187:1124-8.
19. Toba M, Hayashida K, Imakita S, Fukuchi K, Kume N, Shimotsu Y, et al. Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med. 1998;12:153-5. (Pubitemid 28345629)
20. Sahlmann CO, Siefker U, Meller J. Dual time point 2-[18F]fluoro-20- deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl Med Commun. 2004;25:819-23. (Pubitemid 39099995)
21. Israel O, Goldberg A, Nachtigal A, Militianu D, Bar-Shalom R, Keidar Z, et al. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Eur J Nucl Med Mol Imaging. 2006;33:1280-4. (Pubitemid 44630782)
22. Nakai T, Okuyamal C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:1253-8. (Pubitemid 41598715)